The global cold, allergy, and sinus tablet market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The factors such as rising demand for over-the-counter (OTC) medicines, as well as increasing air pollution, and the increasing pharmaceutical R&D spending, is driving the growth of the market. Additionally, the market is growing owing to the rising prevalence of asthma and the growing geriatric population.
Moreover, the market is also growing due to the COVID-19 pandemic, which increased the demand and sales of OTC drugs for the management of common symptoms such as cough, cold, flu, rhinitis. Apart from this, North America is expected to hold a prominent share in the market owing to the presence of well established pharmaceutical brands that have a strong brand image. Furthermore, the market is growing due to FDA approvals. For instance, in March 2021, Merck announced the acceptance of a New Drug Application (NDA) for gefapixant from the US Food and Drug Administration (FDA). It is an orally administered, selective P2X3 receptor antagonist used for the treatment of refractory chronic cough (RCC) or unexplained chronic cough (UCC) in adults.
To Request a Sample of our Report on Cold, Allergy, and Sinus Tablet Market: https://www.omrglobal.com/request-sample/cold-allergy-and-sinus-tablet-market
Some major players in the market include Merck & Co., Inc., Bayer AG, and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Cadila Pharmaceuticals Ltd. announced the launch of Bilastine syrup (30 ml) and Bilastine tablets in the strength of 20mg. It is an antihistamine drug that is used for the treatment of allergic rhinitis.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Merck & Co., Inc., Bayer AG, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Cold, Allergy, and Sinus Tablet Market is Available @ https://www.omrglobal.com/industry-reports/cold-allergy-and-sinus-tablet-market
Global Cold, Allergy and Sinus Tablet Market Report by Segment
By Type
- Cold Tablet
- Allergy Tablet
- Sinus Tablet
By Application
- Hospital
- Clinic
- Others
Global Cold, Allergy and Sinus Tablet Market Report by Region
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
